NEWS PROVIDED BYMeticulous Market Research Pvt. Ltd.
May 23, 2024, 10:31 ET
REDDING, Calif., May 23, 2024 /PRNewswire/ — According to a new market research report titled, ‘Healthcare Artificial Intelligence Market by Offering (Software, Services), Technology (ML, NLP), Application (Hospital Workflow Management, Patient Management), End User (Hospitals & Diagnostic Centers), and Geography – Global Forecast to 2031‘, the global healthcare artificial intelligence market is projected to reach $176.4 billion by 2031, at a CAGR of 31.3% from 2024–2031.
Download Sample Report Now- https://www.meticulousresearch.com/download-sample-report/cp_id=4937
Healthcare is one of the most critical sectors in the broader landscape of big data because of its fundamental role in a productive, thriving society. AI in healthcare is a term used to describe the application of machine learning (ML) algorithms and other cognitive technologies in medical settings. AI helps to assist doctors, nurses, and other healthcare workers in their daily work. AI in healthcare enhances preventive care and quality of life, produces more accurate diagnoses and treatment plans, and leads to better patient outcomes overall. AI in healthcare helps to predict and track the spread of infectious diseases by analyzing data from government, healthcare, and other sources.
The growth of the healthcare artificial intelligence market is driven by the growing demand for personalized therapy, the rise in the volume and complexities associated with healthcare datasets, and the rising need to reduce healthcare costs. However, reluctance to adopt AI technologies due to a lack of trust restrains the growth of this market. Moreover, the growing potential of AI-based tools in the treatment of chronic and infectious diseases and the rising incorporation of AI in clinical trials to accelerate new drug launches are expected to generate market growth opportunities. However, discrepancies arising due to upgrades and human barriers to AI adoption are major challenges for market stakeholders. Additionally, growing AI-based clinical decision support systems (CDSS) to identify patient risk are prominent trends in this market.
The global healthcare artificial intelligence market is segmented by offering (software, hardware, and services [installation & integration and support & maintenance]), technology (machine learning, natural language processing, context-aware processing, and querying method), application (drug discovery, hospital workflow management, patient data & risk analytics, medical imaging & diagnosis, patient management, precision medicine, and other applications), end user (hospitals & diagnostic centers, pharmaceutical & biotechnology companies, healthcare payers, patients, and other end users). The study also evaluates industry competitors and analyzes the market at geographical levels.
Get a Glimpse Inside: Request Sample Pages- https://www.meticulousresearch.com/request-sample-report/cp_id=4937
Based on offering, in 2024, the software segment is expected to account for the largest share of the global healthcare artificial intelligence market. However, the services segment is projected to register the highest CAGR during the forecast period due to the rising incorporation of AI services in clinical trials to accelerate new drug launches, the rising adoption of AI services to help reduce human error, assist medical professionals and staff, the increasing need for analyzing data to identify potential health issues.
Based on technology, in 2024, the natural language processing segment is expected to account for the largest share of the global healthcare artificial intelligence market. The segment’s large share is attributed to the growing ability to collect large amounts of data and handle big data, the rising need to organize physician documentation, and the increasing use of efficient back-end coding to optimize billing procedures. Additionally, this segment is expected to register the highest CAGR during the forecast period.
Based on application, in 2024, the hospital workflow management segment is expected to account for the largest share of the global healthcare artificial intelligence market. The segment’s large share is attributed to the increasing use of chatbots for customer service engagement, the growing adoption of automated tasks, improved patient care coordination, reduced costs, and the increasing use of AI in hospitals to improve patient experience and care. Additionally, this segment is expected to register the highest CAGR during the forecast period.
Have Specific Research Needs? Request a Customized Report-
Based on end user, in 2024, the hospitals & diagnostic centers segment is expected to account for the largest share of the global healthcare artificial intelligence market. The segment’s large share is attributed to the growing need to improve the speed and accuracy of patient visits, leading to faster and more personalized care and the growing adoption of AI to improve accuracy, reduce costs, and save time compared to traditional diagnostic methods. Additionally, this segment is expected to register the highest CAGR during the forecast period.
Based on geography, in 2024, North America is expected to account for the largest share of the global healthcare artificial intelligence market. The healthcare industry in North America has swiftly used AI to increase efficiency, productivity, and consumer experiences. The rising incorporation of AI in clinical trials to accelerate new drug launches and the growing demand for personalized therapy support the growth of this regional market.
However, the Asia-Pacific region is projected to register the highest CAGR during the forecast period. This region’s growth is driven by the growing need for coordination between the healthcare workforce and patients, remarkable growth in venture capital investments, the significant use of big data in the healthcare sector, and rising technological innovation.
The key players operating in the healthcare artificial intelligence market are NVIDIA Corporation (U.S.), Google LLC (U.S.) (A Subsidiary of Alphabet Inc.), Intel Corporation (U.S.), International Business Machines Corporation (U.S.), Microsoft Corporation (U.S.), GE HealthCare Technologies Inc. (U.S.), Amazon.com, Inc. (U.S.), Verint Systems Inc. (U.S.), General Vision, Inc. (U.S.), Siemens Healthineers AG (Germany), CloudMedx Inc. (U.S.), AltexSoft Inc. (U.S.), IQVIA Holdings Inc. (U.S.), Welltok, Inc. (U.S.), and iCarbonX (China).
Browse In-depth Report Now- https://www.meticulousresearch.com/product/healthcare-artificial-intelligence-market-4937
Scope of the Report:
Healthcare Artificial Intelligence Market, by Offering
- Software
- Services
- Installation & Integration
- Support & Maintenance
- Hardware
Healthcare Artificial Intelligence Market, by Technology
- Natural Language Processing
- Context-Aware Processing
- Machine Learning
- Querying Method
Healthcare Artificial Intelligence Market, by Application
- Drug Discovery
- Hospital Workflow Management
- Patient Data & Risk Analytics
- Medical Imaging & Diagnosis
- Patient Management
- Precision Medicine
- Other Applications
Healthcare Artificial Intelligence Market, by End User
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Healthcare Payers
- Patients
- Other End Users
Healthcare Artificial Intelligence Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Singapore
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
Unlock Opportunities: Buy Now- https://www.meticulousresearch.com/Checkout/39869176
Related Reports:
Conversational AI Market by Offering, Application, Organization Size, Deployment Mode, Sector (IT & Telecommunications, BFSI, Retail & E-commerce, Healthcare & Life Sciences, Travel & Hospitality, Education, Manufacturing) – Global Forecast to 2030
Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospital, Diagnostic Center) – Global Forecast to 2029
Artificial Intelligence in Drug Discovery Market by Offering (Software, Service), Application (Target Discovery, Lead Identification, Clinical Testing), Therapy Area (Oncology, Cardiology, Neurodegenerative), Deployment, End User—Global Forecast to 2030
Related Blog:
Top 10 Companies in Healthcare Artificial Intelligence Market
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/297/healthcare-artificial-intelligence-market-2031
Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
SOURCE Meticulous Market Research Pvt. Ltd.